Profile data is unavailable for this security.
About the company
Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.
- Revenue in CHF (TTM)839.38k
- Net income in CHF30.75m
- Incorporated2013
- Employees17.00
- LocationXlife Sciences AGTalacker 35ZUERICH 8001SwitzerlandCHE
- Phone+41 443858460
- Websitehttps://www.xlifesciences.ch/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope Fluidics SA | 155.34k | 11.79m | 98.71m | 132.00 | 7.20 | 3.40 | 8.08 | 635.42 | 19.99 | 19.99 | 0.2633 | 42.35 | 0.0065 | 0.9348 | 10.80 | 11,396.83 | 49.25 | 54.44 | 52.79 | 58.98 | -178.69 | -440.53 | 7,586.77 | 33,272.12 | 12.82 | -- | 0.0212 | -- | -74.61 | -- | 448.26 | -- | 5.75 | -- |
| Nykode Therapeutics ASA | 5.19m | -8.43m | 99.40m | 62.00 | -- | 1.31 | -- | 19.16 | -0.3093 | -0.3093 | 0.1939 | 2.88 | 0.0494 | -- | 1.91 | 461,762.70 | -8.03 | 2.32 | -8.66 | 2.60 | -- | -- | -162.46 | 8.51 | -- | -- | 0.0284 | -- | -32.73 | -- | -10.43 | -- | -1.35 | -- |
| XSpray Pharma AB (publ) | 0.00 | -18.62m | 100.20m | 26.00 | -- | 1.81 | -- | -- | -5.96 | -5.96 | 0.00 | 15.37 | 0.00 | -- | -- | 0.00 | -29.09 | -23.48 | -30.93 | -25.08 | -- | -- | -- | -- | 5.93 | -18.44 | 0.1883 | -- | -- | -- | -58.92 | -- | -14.46 | -- |
| Cantargia AB | 26.56m | 12.04m | 111.65m | 23.00 | 10.30 | 4.36 | 9.05 | 4.20 | 0.5068 | 0.5068 | 1.33 | 1.20 | 1.41 | -- | 164.02 | 14,031,360.00 | 63.91 | -56.56 | 80.65 | -63.93 | -- | -- | 45.33 | -- | -- | 76.55 | 0.00 | -- | -- | -- | 42.27 | -- | -- | -- |
| Darwin AG | -91.11bn | -91.11bn | 113.70m | 235.00 | -- | 1.21 | -- | -- | -- | -- | -- | 8.61 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.10 | -- | 0.0547 | -- | 39.21 | -- | 45,480.41 | -- | -- | -- |
| Adocia SA | 9.43m | -8.85m | 113.97m | 77.00 | -- | -- | -- | 12.09 | -0.5622 | -0.5622 | 0.6343 | -0.0338 | 0.4068 | -- | 2.55 | 134,428.60 | -38.16 | -47.62 | -184.08 | -104.50 | -- | -- | -93.83 | -331.17 | 1.12 | -14.58 | 1.06 | -- | 333.49 | 34.18 | 55.95 | -- | -35.29 | -- |
| Abionyx Pharma SA | 3.94m | -4.19m | 115.99m | 51.00 | -- | 22.66 | -- | 29.43 | -0.1317 | -0.1317 | 0.1238 | 0.1582 | 0.3033 | 17.39 | 7.16 | 84,823.53 | -32.25 | -26.53 | -43.11 | -38.31 | 17.78 | 15.59 | -106.31 | -131.06 | 1.35 | -- | 0.4281 | -- | -1.92 | -- | -24.53 | -- | -- | -- |
| Xlife Sciences AG | 839.38k | 30.75m | 118.24m | 17.00 | 5.03 | 0.3879 | 2.87 | 140.86 | 4.08 | 4.08 | 0.1284 | 52.84 | 0.0016 | -- | 0.0907 | 49,375.29 | 4.80 | 6.01 | 5.95 | 7.37 | 62.17 | 37.44 | 2,991.34 | 2,987.92 | 1.07 | -- | 0.131 | -- | -15.54 | 10.15 | 130.37 | 100.79 | -13.48 | -- |
| Nightingale Health Oyj | 4.28m | -16.82m | 124.15m | 100.00 | -- | 1.53 | -- | 29.04 | -0.3052 | -0.3052 | 0.0778 | 1.10 | 0.0568 | 0.9444 | 2.79 | 46,930.00 | -22.33 | -15.66 | -24.26 | -16.95 | 75.39 | 75.21 | -393.39 | -447.17 | 8.52 | -- | 0.0511 | -- | 7.69 | 21.38 | -5.71 | -- | -12.69 | -- |
| Innate Pharma SA | 5.47m | -41.96m | 125.38m | 181.00 | -- | 26.30 | -- | 22.94 | -0.5497 | -0.5497 | 0.0714 | 0.0558 | 0.0491 | -- | 15.81 | 33,149.17 | -37.68 | -13.19 | -52.10 | -17.17 | 49.52 | 91.15 | -767.52 | -88.46 | -- | -- | 0.8401 | -- | -75.68 | -28.80 | -553.51 | -- | -64.08 | -- |
| Ryvu Therapeutics SA | 15.10m | -25.68m | 125.80m | 294.00 | -- | 8.16 | -- | 8.33 | -5.13 | -5.13 | 3.02 | 3.08 | 0.212 | 12.29 | 7.31 | 237,411.60 | -36.05 | -23.64 | -48.51 | -27.84 | 70.86 | 29.35 | -170.05 | -208.85 | 2.26 | -- | 0.572 | -- | 66.38 | 83.01 | -20.98 | -- | -24.46 | -- |
| Solar Foods Oyj | 17.41k | -9.72m | 127.96m | 57.00 | -- | 6.61 | -- | 7,349.74 | -0.433 | -0.433 | 0.0008 | 0.7115 | 0.0004 | -- | 0.0037 | 455.00 | -22.45 | -- | -27.05 | -- | 25,931.57 | -- | -55,808.37 | -- | -- | -7.03 | 0.5092 | -- | 275.15 | -- | -22.57 | -- | -- | -- |
| Heidelberg Pharma AG | 2.77m | -23.85m | 129.58m | 114.00 | -- | 13.51 | -- | 46.82 | -0.558 | -0.558 | 0.0647 | 0.2251 | 0.0507 | 0.0329 | 69.14 | 28,928.10 | -43.69 | -40.90 | -50.29 | -58.51 | 84.66 | 55.95 | -861.83 | -228.64 | 3.55 | -- | 0.7766 | -- | -30.53 | -1.29 | 4.74 | -- | -13.09 | -- |
| Maat Pharma SA | 3.57m | -28.36m | 133.43m | 60.00 | -- | 15.13 | -- | 37.34 | -2.15 | -2.15 | 0.270 | 0.5141 | 0.0786 | 11.22 | 0.5785 | 65,366.67 | -62.39 | -41.51 | -90.20 | -51.87 | 61.68 | -- | -793.83 | -976.99 | 2.21 | -29.53 | 0.6346 | -- | 44.34 | -- | -46.59 | -- | 42.53 | -- |
| Intellego Technologies AB | 66.32m | 25.35m | 133.59m | 65.00 | 4.75 | 2.33 | 4.81 | 2.01 | 9.81 | 9.81 | 25.91 | 20.01 | 1.28 | 10.59 | 2.32 | 12,432,400.00 | 49.11 | 17.13 | 61.64 | 23.87 | 70.97 | 58.82 | 38.23 | 21.32 | 4.11 | 5.35 | 0.0617 | -- | 42.25 | 222.71 | 14.78 | -- | -- | -- |
| BioVersys AG | -100.00bn | -100.00bn | 135.67m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.28 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Xlife Sciences AG's reporting currency: Swiss Franc CHF
3.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 06 Jan 2026 | 68.78k | 1.19% |
| Monega Kapitalanlagegesellschaft mbHas of 30 Dec 2025 | 45.00k | 0.78% |
| Baader Bank AG (Investment Management)as of 28 Nov 2025 | 43.10k | 0.75% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2025 | 21.86k | 0.38% |
| BlackRock Asset Management Deutschland AGas of 08 Jan 2026 | 7.44k | 0.13% |
| Pictet Asset Management SAas of 31 Oct 2025 | 5.97k | 0.10% |
| DWS CH AGas of 31 Oct 2025 | 3.28k | 0.06% |
| Gutmann Finanz Strategien AGas of 31 Dec 2025 | 2.05k | 0.04% |
| Swiss Life Asset Management AGas of 30 Sep 2025 | 1.38k | 0.02% |
| Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 30 Nov 2024 | 1.13k | 0.02% |
More ▼
Data from 30 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
